Reimbursement During a Clinical Trial
Determines whether sites can bill for your investigational device
Key Outcomes
Reduced financial exposure during clinical trials
Faster startup and stronger site participation
Compliance with Medicare coverage analysis for device trials
Predictable trial budgeting, forecasting, and commercial planning
Reimbursement during a clinical trial determines whether sites can bill payers for routine care services or whether all costs, including the investigational device, fall back on the sponsor. Many devices are eligible for billing under existing Medicare and commercial payer rules, but only when the sponsor completes a compliant Medicare coverage analysis for device trials, builds a detailed billing grid, and implements a structured clinical trial billing compliance program. When this work is not completed, sponsors are required to provide the device and supplies at no charge. For pivotal trials, this becomes a significant and avoidable cost that directly affects commercial runway and investor expectations.
Our team builds the investigational device reimbursement framework that protects sponsors from unnecessary financial exposure and supports fast, compliant site activation.
CHALLENGES
If Clinical Trial Reimbursement Is Not Structured Correctly
Without a compliant clinical trial reimbursement foundation
Sponsors must provide the device and supplies at no cost
Case volume amplifies cost exposure in pivotal trials
Sites delay startup due to financial uncertainty
Medicare and commercial payers may recoup payments
Trial budgets become inaccurate and commercial readiness suffers
Site satisfaction declines and enrollment slows
These outcomes are preventable with correct planning
OUR PROCESS
How We Structure Reimbursement for Device Trials
UnifiMed structures device trial reimbursement as an integrated component of clinical trial strategy, design, site activation, and commercial planning
Medicare Coverage Analysis
We assess Medicare investigational device policy, IDE classification, routine cost eligibility, and applicable payment rules to define what trial elements are billable versus sponsor funded under CMS requirements
Clinical Trial Billing Compliance
We establish a compliant billing structure with coding standards, documentation controls, and SOPs to prevent double billing, align with CMS clinical research rules, and reduce recoupment risk
Device Billing Determination
We determine whether the investigational device qualifies as a billable routine cost based on IDE status, existing codes, and payer criteria, or define sponsor cost exposure and financial implications
Pivotal Trial Reimbursement Strategy
We model reimbursement risk, forecast device supply obligations, align payer expectations, and integrate site contracting to ensure pivotal trials remain financially controlled and commercially aligned
Site and Investigator Payments
We structure site budgets, payment schedules, and reconciliation workflows aligned to regulatory and payer rules to accelerate site startup, ensure transparency, and minimize payment disputes
Clinical Trial Operations Integration
We integrate reimbursement guidance into trial startup and activation materials, define escalation pathways, and align reimbursement workflows with feasibility, early feasibility, and pivotal trial execution
Ready to Learn More?
Contact our team to discuss how we can support your clinical trial reimbursement needs